Clive Meanwell - 22 Jun 2022 Form 4 Insider Report for Adagio Therapeutics, Inc. (IVVD)

Role
Director, 10%+ Owner
Signature
/s/ Jill Andersen attorney-in-fact for Clive Meanwell
Issuer symbol
IVVD
Transactions as of
22 Jun 2022
Net transactions value
$0
Form type
4
Filing time
24 Jun 2022, 17:01:31 UTC
Previous filing
30 Mar 2022
Next filing
04 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IVVD Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 22 Jun 2022 Common Stock 150,000 $3.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 22, 2022 and vests over a three-year period, with one-third of the shares subject to the grant vesting on the first anniversary of the grant date and 1/36th of the shares subject to the grant vesting in equal monthly installments thereafter, subject to continued service through each vesting date.

Remarks:

Exhibit Index: 24.1 Power of Attorney